Claire Dawson
Memorial Sloan Kettering Cancer Center (MSK or MSKCC) is a private cancer treatment and research institution in Manhattan, New York City. It is the world's oldest and largest private institution devoted to the prevention, treatment, and cure of cancer. The hospital was founded in 1884 as the Memorial Hospital for the Treatment of Cancer and Allied Diseases and merged with the Sloan-Kettering Institute for Cancer Research in 1980 to become the Memorial Sloan Kettering Cancer Center. The center has consistently ranked as one of the Best Hospitals for Cancer and is recognized for its innovative treatments and research.
| Characteristics | Values |
|---|---|
| Name | Memorial Sloan Kettering Cancer Center (MSK) |
| Type | Private |
| Location | 1275 York Avenue, Manhattan, New York City, New York |
| Year founded | 1980 |
| Specialty | Cancer treatment and research |
| Ranking | Top two "Best Hospitals for Cancer" every year since U.S. News & World Report began rating hospitals in 1990 |
| Notable achievements | One of 72 National Cancer Institute–designated Comprehensive Cancer Centers, development of innovative immunotherapy treatments, purification of human G-CSF in 1985 |
| Notable patients | The author Steven Petrow and his family |
Explore related products
What You'll Learn
- Memorial Sloan Kettering Cancer Center is the oldest and largest private cancer institution
- The hospital was formed in 1980 through the merger of Memorial Hospital and the Sloan-Kettering Institute
- MSK has ranked in the top two Best Hospitals for Cancer since 1990
- The hospital has been criticised for its hidden business deals and undisclosed payments to doctors
- MSK has locations in New York, New Jersey, and Long Island
Memorial Sloan Kettering Cancer Center is the oldest and largest private cancer institution
Memorial Sloan Kettering Cancer Center (MSK or MSKCC) is a private cancer treatment and research institution in Manhattan, New York City. It is the oldest and largest private cancer institution, founded in 1884 as the New York Cancer Hospital. The hospital was founded by a group that included John Jacob Astor III and his wife, Charlotte.
MSK has consistently ranked as one of the "Best Hospitals for Cancer" by U.S. News & World Report since 1990. It is one of 72 National Cancer Institute-designated Comprehensive Cancer Centers and is recognised for its top care in New York and New Jersey. The main campus is located at 1275 York Avenue between 67th and 68th Streets in Manhattan.
The institution was formed in 1980 through the merger of the Memorial Hospital for the Treatment of Cancer and Allied Diseases and the Sloan-Kettering Institute for Cancer Research, which were founded in 1884 and 1945, respectively. The Memorial Hospital was established through donations from John D. Rockefeller Jr., who provided funds for land and relocation, and Alfred P. Sloan, who donated $4 million to create the Sloan-Kettering Institute through his Sloan Foundation.
MSK has a long history of leadership in cancer treatment, early detection, precise diagnosis, and individually tailored treatments. The institution is committed to patient care, education, and innovative research, with a unique strength in the close collaboration between its scientists and physicians. MSK offers cutting-edge treatments, such as checkpoint inhibitors, an innovative immunotherapy treatment, to its patients. Additionally, MSK has established centres dedicated to integrative medicine, image-guided intervention, rehabilitation, and proton therapy, further demonstrating its commitment to comprehensive cancer care.
Pope's Health Scare: Hospitalization Reasons Revealed
You may want to see also
Explore related products
The hospital was formed in 1980 through the merger of Memorial Hospital and the Sloan-Kettering Institute
Memorial Sloan Kettering Cancer Center (MSK or MSKCC) is a private cancer treatment and research institution in Manhattan, New York City. The hospital was formed in 1980 through the merger of Memorial Hospital and the Sloan-Kettering Institute.
Memorial Hospital, or the Memorial Hospital for the Treatment of Cancer and Allied Diseases, was founded in 1884. In 1934, John D. Rockefeller Jr. donated land on York Avenue for a new location and $3 million (equivalent to $68 million in 2024) to fund the hospital's move. The hospital officially reopened at the new location in 1939.
The Sloan-Kettering Institute for Cancer Research was founded in 1945 following a $4 million donation (equivalent to $69.9 million in 2024) from Alfred P. Sloan, the chairman of General Motors. The institute was built adjacent to Memorial Hospital, and the two institutions formally coordinated their operations from 1960 onwards. In 1960, Memorial Sloan Kettering Cancer Center was formed as a new corporation to manage the two entities, and John Heller, the former director of the National Cancer Institute, was appointed its president.
In 1980, Memorial Hospital and the Sloan-Kettering Institute formally merged to become Memorial Sloan Kettering Cancer Center. The institution is the world's oldest and largest private institution dedicated to cancer prevention, treatment, and cure. It has consistently ranked as one of the top two "Best Hospitals for Cancer" by U.S. News & World Report and has been designated as a Comprehensive Cancer Center by the National Cancer Institute. MSK has a main campus in Manhattan and offers treatments and services across New York and New Jersey.
The Memorial Sloan Kettering Bendheim Integrative Medicine Center, a standalone outpatient facility, was developed in 1999. The center offers innovative treatments, such as immunotherapy, and has established various services, including a full-time psychiatric service in 1977 and an outpatient pediatric day hospital in the late 1960s.
Federal or State: VA Hospitals' Confusing Status
You may want to see also
Explore related products
MSK has ranked in the top two Best Hospitals for Cancer since 1990
Memorial Sloan Kettering Cancer Center (MSK) is a cancer treatment and research institution in Manhattan, New York City. It was formed in 1980 from the merger of the Memorial Hospital for the Treatment of Cancer and Allied Diseases and the Sloan-Kettering Institute for Cancer Research.
MSK has ranked in the top two Best Hospitals for Cancer since U.S. News & World Report began rating hospitals in 1990. It has been recognised as the best cancer centre in the Northeast and the second-best cancer hospital in the nation. The centre has also been recognised for its groundbreaking contributions to cancer research, patient care and education.
MSK has consistently been acknowledged as one of the top two cancer hospitals in the nation for over three decades. This recognition is a testament to the depth and breadth of its expertise in cancer care and the dedication and compassion of its staff. The centre has also been recognised for its innovative immunotherapy treatments, such as checkpoint inhibitors, which have successfully treated several cancers with MMRd mutations and improved patients' quality of life.
The Memorial Sloan Kettering Bendheim Integrative Medicine Centre, a stand-alone outpatient facility, was developed in 1999. The centre offers a range of treatments and services across New York and New Jersey, including telemedicine. In 2020, the David H. Koch Centre for Cancer Care at MSK opened its doors, further expanding the centre's capacity and commitment to providing world-class cancer care.
In addition to its clinical achievements, MSK has also been recognised for its research contributions. In 2025, TIME recognised two MSK physician-scientists, Andrea Cercek and Vinod Balachandran, as some of the most influential individuals in health. The centre actively encourages research and innovation, offering triple-matched funding for life-changing cancer research and care.
Temple University Hospital: A Leading Trauma Center?
You may want to see also
Explore related products
The hospital has been criticised for its hidden business deals and undisclosed payments to doctors
Memorial Sloan Kettering Cancer Center (MSK or MSKCC) is a cancer treatment and research institution in Manhattan, New York City. It was formed in 1980 from the merger of the Memorial Hospital for the Treatment of Cancer and Allied Diseases and the Sloan-Kettering Institute for Cancer Research. The hospital has been criticised for its hidden business deals and undisclosed payments to doctors.
In 2018, Memorial Sloan Kettering faced criticism for its business arrangements, including one in which the cancer centre gave exclusive rights to anonymised images of patient pathology slides to a private entity whose investors included MSK's clinical leaders and board members. The centre has also been criticised for its collaboration with IBM in the development and sale of Watson for Oncology, a product that combines clinical expertise with artificial intelligence to deliver cancer treatment recommendations. Memorial Sloan Kettering receives royalties on the sale of this product.
In addition, ethics experts have raised concerns about the centre's partnerships with a New Jersey hospital and a data analytics startup, creating a web of interlocking financial interests and conflicts. There are doubts about whether the hospital can always put its patients' interests first while using their medical records to make money. Memorial Sloan Kettering has also faced criticism for its deal with Hackensack Meridian Health, which gave the cancer centre access to a larger patient pool and protected it from competition. The centre has also invested $1.4 million in a data analytics startup called Cota, with which it will share revenues based on the use of its anonymised patient data.
Furthermore, there have been concerns about the commercialisation of patients' medical data without their consent. For instance, when startup company Y-mAbs Therapeutics, funded in part by Memorial Sloan Kettering, went public, Dr Gregory Raskin, a vice president who oversees the hospital's ventures with for-profit companies, stood to personally profit from the deal by nearly $1.4 million. These issues have led to a sense of betrayal among patients and their families, who have received treatment at the hospital for many years.
Paul Onions: Still in Ashworth Hospital?
You may want to see also
Explore related products
MSK has locations in New York, New Jersey, and Long Island
Memorial Sloan Kettering Cancer Center (MSK or MSKCC) is a private cancer treatment and research institution with locations in New York, New Jersey, and Long Island. It was formed in 1980 from the merger of the Memorial Hospital for the Treatment of Cancer and Allied Diseases, founded in 1884, and the adjacent Sloan-Kettering Institute for Cancer Research, founded in 1945. The two medical entities had formally coordinated their operations since 1960.
MSK's main campus is located at 1275 York Avenue between 67th and 68th Streets in Manhattan, New York. The hospital was founded in its original building on the Upper West Side of Manhattan in 1884 as the New York Cancer Hospital by a group that included John Jacob Astor III and his wife, Charlotte.
In addition to its main campus, MSK has several other locations in New York, New Jersey, and Long Island. These include the Bendheim Integrative Medicine Center, a stand-alone outpatient facility that was developed from the Integrative Medicine Service that began in 1999. The Center for Image-Guided Intervention was opened in June 2010 in the Memorial Hospital building to oversee image-guiding activities across MSK. The Sillerman Center for Rehabilitation was opened in October 2012, moving rehabilitation services out of Memorial Hospital and closer to the Rockefeller Outpatient Pavilion.
MSK also has partnerships with other healthcare providers in New York, such as the New York Proton Center, which opened in 2019 as a partnership between MSK, Montefiore Health, and Mount Sinai Health System. This center was the first proton therapy center to open in New York State. Another MSK location in New York is the David H. Koch Center for Cancer Care, which opened in January 2020 at 530 East 74th Street between York Avenue and FDR Drive.
MSK has consistently been ranked as one of the top "Best Hospitals for Cancer" by U.S. News & World Report since the publication began rating hospitals in 1990. It is also one of 72 National Cancer Institute-designated Comprehensive Cancer Centers and is recognised as a leader in early detection, precise diagnosis, and individually tailored treatments for cancer.
Perrysburg Hospital: Where is it Located?
You may want to see also
Frequently asked questions
Yes, Memorial Sloan Kettering Cancer Center (MSK) is a private hospital. It is the world's oldest and largest private institution devoted to the prevention, treatment, and cure of cancer.
Memorial Sloan Kettering was founded in 1980 from the merger of the Memorial Hospital for the Treatment of Cancer and Allied Diseases, founded in 1884, and the Sloan-Kettering Institute for Cancer Research, founded in 1945.
Memorial Sloan Kettering is located at 1275 York Avenue, New York, NY.
Memorial Sloan Kettering is known for being a leader in early cancer detection, precise diagnosis, and individually tailored treatments. It has ranked in the top two "Best Hospitals for Cancer" every year since U.S. News & World Report began rating hospitals in 1990.
Memorial Sloan Kettering has many notable achievements, including pioneering early forms of immunotherapy to eradicate tumors, establishing a full-time psychiatric service dedicated to helping people with cancer, and being designated as one of only three Comprehensive Cancer Centers nationwide by the National Cancer Act of 1971.
